Citation: | LUO Huiying, WU Bumei, MA Tianyue, et al. Based on Network Pharmacology and Molecular Docking to Discuss the Mechanism of Antitussive and Expectorant Action of Ruanerli[J]. Science and Technology of Food Industry, 2023, 44(23): 11−20. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2023010103. |
[1] |
吕艳杭, 黄文宝, 陈卿倩, 等. 《伤寒论》咳嗽病六经辨治规律与临床应用[J]. 环球中医药,2021,14(4):722−726. [LÜ Y H, HUANG W B, CHEN Q Q, et al. Treatise on Febrile Diseases " cough disease six meridians syndrome differentiation and clinical application of law and clinical application[J]. Global Journal of Traditional Chinese Medicine,2021,14(4):722−726. doi: 10.3969/j.issn.1674-1749.2021.04.044
|
[2] |
朱育红, 王怡. 治疗咳嗽中成药的辩证使用[J]. 首都医药,2012,19(6):46−47. [ZHU Y H, WANG Y. The dialectical use of Chinese patent medicine in the treatment of cough[J]. Capital Medicine,2012,19(6):46−47.
|
[3] |
李为贵. 从虚证、寒证论治慢性咳嗽[J]. 湖北中医杂志,2012,34(4):34−35. [LI W G. Treating chronic cough from deficiency syndrome and cold syndrome[J]. Hubei Journal of Traditional Chinese Medicine,2012,34(4):34−35. doi: 10.3969/j.issn.1000-0704.2012.04.017
|
[4] |
潘家文. 基于数据挖掘的感染后咳嗽中医药规律研究[D]. 广州:广州中医药大学, 2019. [PAN J W. Data mining on the treatment of postinfectious cough by traditional chinese medicine[D]. Guangzhou:Guangzhou University of Chinese Medicine, 2019.
PAN J W. Data mining on the treatment of postinfectious cough by traditional chinese medicine[D]. Guangzhou: Guangzhou University of Chinese Medicine, 2019.
|
[5] |
谢剑鹏, 李建生, 王至婉等. 基于现代名老中医经验的咳嗽病因病机及证素规律研究[J]. 中华中医药杂志,2016,31(4):1409−1412. [XIE J P, LI J S, WANG Z W, et al. Regularity of etiology pathogenesis and syndrome factors of cough based on the experience of modern famous doctors of traditional Chinese medicine[J]. Chinese Journal of Traditional Chinese Medicine,2016,31(4):1409−1412.
|
[6] |
张作良, 康晓文, 梁永林等. 浅析"五脏六腑皆令人咳, 非独肺也"[J]. 中国中医药信息杂志,2019,26(10):124−126. [ZHANG Z L, KANG X W, LIANG Y L, et al. Analysis on “The Viscera all cause cough, not only Lung”[J]. Chinese Journal of Traditional Chinese Medicine Information,2019,26(10):124−126. doi: 10.3969/j.issn.1005-5304.2019.10.029
|
[7] |
符琼方, 胡朋, 杨文秀等. 钩藤饮子合小青龙汤辨证治疗咳嗽变异性哮喘(风邪犯肺证)的效果及对外周血白三烯D4、C4及尿白三烯E4水平的影响[J]. 天津中医药大学学报,2022,41(3):317−321. [FU Q F, HU P, YANG W X, et al. Efficacy of Gouteng Yinzi with Xiaoqinglong decoction in the dialectical treatment of cough variant asthma (pathogenic wind invading the lung) and its influence on levels of peripheral blood leukotriene D4 and C4 and urinary leukotriene E4[J]. Journal of Tianjin University of Traditional Chinese Medicine,2022,41(3):317−321.
|
[8] |
薛贝, 张毅杰, 张山等. 基于数据挖掘的中医药治疗感染后咳嗽用药规律研究[J]. 现代中西医结合杂志,2022,31(13):1854−1858,1864. [XUE B, ZHANG Y J, ZHANG S, et al. Research on the medication rule of traditional Chinese medicine in the treatment of post-infectious cough based on data mining[J]. Journal of Modern Integrated Traditional Chinese and Western Medicine,2022,31(13):1854−1858,1864. doi: 10.3969/j.issn.1008-8849.2022.13.022
|
[9] |
高彐媚, 黄振炎, 黄慧欣. 养阴清肺法治疗燥热伤肺型喉源性咳嗽临床疗效观察[J]. 广州中医药大学学报,2022,39(6):1274−1279. [GAO X M, HUANG Z Y, HUANG H X. Clinical observation on the effect of therapy of Nourishing Yin to clear lung for the treatment of laryngeal cough with Dryness-heat impairing lung syndrome[J]. Journal of Guangzhou University of Traditional Chinese Medicine,2022,39(6):1274−1279. doi: 10.13359/j.cnki.gzxbtcm.2022.06.009
|
[10] |
王程, 杨来胜, 杨磊. 甘味品牌—兰州软儿梨[J]. 西北园艺(果树), 2022(4):65−67. [WANG C, YANG L S, YANG L, Sweet brand —Lanzhou Ruanerli [J]. Northwest Horticulture (fruit trees), 2022(4):65−67.
WANG C, YANG L S, YANG L, Sweet brand —Lanzhou Ruanerli [J]. Northwest Horticulture (fruit trees), 2022(4): 65−67.
|
[11] |
黄毅君. 软儿梨和热冬果[J]. 中医健康养生, 2017(11):69. [HUANG Y J, Ruanerli and Redongguo[J]. Chinese Medicine Health, 2017(11):69.
HUANG Y J, Ruanerli and Redongguo[J]. Chinese Medicine Health, 2017(11): 69.
|
[12] |
张忠, 马朝玲, 丁若珺, 等. 不同解冻方式对软儿梨果实品质与抗氧化物质含量的影响[J]. 食品科学,2018,39(3):236−244. [ZHANG Z, MA Z L, DING R J, et al. Effects of different thawing methods on fruit quality and antioxidant compound contents of Ruaner Pear[J]. Food Science,2018,39(3):236−244. doi: 10.7506/spkx1002-6630-201803036
|
[13] |
毛姝英, 金蔚, 付思思, 等. 口服脾多肽改善氨水诱导的小鼠咳嗽和体内炎症[J]. 中国临床药理学与治疗学,2022,27(6):601−607. [MAO Z Y, JING Z, FU S S, et al. Oral lienal peptides improve ammonia-induced coughing and inflammation in mice[J]. Chinese Clinical Pharmacology and Therapeutics,2022,27(6):601−607. doi: 10.12092/j.issn.1009-2501.2022.06.001
|
[14] |
刘泱泱. 艾叶油治疗慢性支气管炎的实验研究[J]. 中国现代药物应用,2022,16(21):186−190. [LIU Y Y. Experimental study on the treatment of chronic bronchitis with mugwort oil[J]. Modern Drug Application in China,2022,16(21):186−190. doi: 10.14164/j.cnki.cn11-5581/r.2022.21.054
|
[15] |
MATSUZAKA Y, YASHIRO R. Molecular docking and intracellular translocation of extracellular vesicles for efficient drug delivery[J]. Int J Mol Sci,2022,23(21):12971. doi: 10.3390/ijms232112971
|
[16] |
GROZA Y, JEMELKOVA J, KAFKOVA L R, et al. IL-6 and its role in IgA nephropathy development[J]. Cytokine Growth Factor Rev,2022,66:1−14. doi: 10.1016/j.cytogfr.2022.04.001
|
[17] |
MILLER C L, MADSEN J C. Targeting IL-6 to prevent cardiac allograft rejection[J]. Am J Transplant,2022,22(S4):12−17.
|
[18] |
FORCINA L, FRANCESCHI C, MUSARÒ A. The hormetic and hermetic role of IL-6[J]. Ageing Res Rev,2022,80:101697. doi: 10.1016/j.arr.2022.101697
|
[19] |
LAMIABLE O, BREWERTON M, RONCHESE F. IL-13 in dermal type-2 dendritic cell specialization:From function to therapeutic targeting[J]. Eur J Immunol,2022,52(7):1047−1057. doi: 10.1002/eji.202149677
|
[20] |
DARCY Q, GHARAEE-KERMANI M, ZHILIN-ROTH A, et al. The IL-4/IL-13 signaling axis promotes prostatic fibrosis[J]. PLoS One,2022,17(10):e0275064. doi: 10.1371/journal.pone.0275064
|
[21] |
ZHANG Y, JING D, CHENG J, et al. The efficacy and safety of IL-13 inhibitors in atopic dermatitis:A systematic review and meta-analysis[J]. Front Immunol,2022,13:923362. doi: 10.3389/fimmu.2022.923362
|
[22] |
GONZÁLEZ L, RIVERA K, ANDIA M E, et al. The IL-1 Family and its role in Atherosclerosis[J]. Int J Mol Sci,2022,24(1):17−42. doi: 10.3390/ijms24010017
|
[23] |
KHAROUF F, TSEMACH-TOREN T, BEN-CHETRIT E. IL-1 inhibition in familial mediterranean fever:Clinical outcomes and expectations[J]. Clin Exp Rheumatol,2022,40(8):1567−1574.
|
[24] |
AHMAD A, NAWAZ M I. Molecular mechanism of VEGF and its role in pathological angiogenesis[J]. J Cell Biochem,2022,123(12):1938−1965. doi: 10.1002/jcb.30344
|
[25] |
CALVO P M, HERNÁNDEZ R G, DELA CRUZ R R, et al. VEGF is an essential retrograde trophic factor for motoneurons[J]. Proc Natl Acad Sci U S A,2022,119(26):e2202912119. doi: 10.1073/pnas.2202912119
|
[26] |
ROHNER E, YANG R, FOO K S, et al. Unlocking the promise of mRNA therapeutics[J]. Nat Biotechnol,2022,40(11):1586−1600. doi: 10.1038/s41587-022-01491-z
|
[27] |
LIU K, ZHAO M, LI Y, et al. VEGF loaded porcine decellularized adipose tissue derived hydrogel could enhance angiogenesis in vitro and in vivo[J]. J Biomater Sci Polym Ed,2022,33(5):569−589. doi: 10.1080/09205063.2021.2002235
|
[28] |
LI S, HAN X, LU Z, et al. MAPK cascades and transcriptional factors:Regulation of heavy metal tolerance in plants[J]. Int J Mol Sci,2022,23(8):4463−4476. doi: 10.3390/ijms23084463
|
[29] |
CHENG Y, CHEN J, SHI Y, et al. MAPK signaling pathway in oral squamous cell carcinoma:Biological function and targeted therapy[J]. Cancers (Basel),2022,14(19):4625−4642. doi: 10.3390/cancers14194625
|
[30] |
XIE Y, DING M, YIN X, et al. MAPKK2/4/5/7-MAPK3-JAZs modulate phenolic acid biosynthesis in Salvia miltiorrhiza[J]. Phytochemistry,2022,199:113177. doi: 10.1016/j.phytochem.2022.113177
|
[31] |
KLINK V P, ALKHAROUF N W, LAWRENCE K S, et al. The heterologous expression of conserved Glycine max (soybean) mitogen activated protein kinase 3 (MAPK3) paralogs suppresses Meloidogyne incognita parasitism in Gossypium hirsutum (upland cotton)[J]. Transgenic Res,2022,31(4-5):457−487. doi: 10.1007/s11248-022-00312-y
|